Dementia Matters

June 4, 2026

Addressing Cochrane’s Review on Amyloid-Targeting Treatments for Alzheimer’s Disease

Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer’s disease therapies after decades of research and clinical trials. A recent review published by Cochrane has a different perspective on these therapies, finding that these treatments produce “little to no difference” in cognition and offer few benefits while increasing risks for adverse effects. Drs. Cynthia Carlsson, a clinical trialist, David Wolk, a clinician, and Henrik Zetterberg, a biomarker and disease biology expert, break down the review and their concerns, as well as highlight how this review could impact care, research and public policy.

may 19, 2026

What to Expect from ‘When Memory Fades’ with Drs. Art Walaszek and Nathaniel Chin

Guest host Dr. Art Walaszek takes over the podcast to interview Dr. Chin about his upcoming book, When Memory Fades. In addition to discussing the importance of dementia research and other clinical topics covered in the book, Dr. Chin shares what drew him to write When Memory Fades, what the writing process was like, and what he hopes readers take away from his story.

May 5, 2026

New Study Examines the Effects of Food Insecurity on Dementia Risk

The latest Household Food Security report estimated that 13.7% of U.S. households experienced food insecurity in 2024. This lack of access to a nutritious diet can significantly affect health, so how does it then impact older adults’ health and their risk for cognitive impairment? Dr. Heejin Lee joins the podcast to share what food insecurity means, what her study found and more.

Guest: Heejin Lee, PhD, postdoctoral research fellow, department of nutrition, Harvard T.H. Chan School of Public Health